AB159. Endocrine disrupting chemicals: toxicological risk assessment in vivo and in vitro models
Part 4: Oral/poster

AB159. Endocrine disrupting chemicals: toxicological risk assessment in vivo and in vitro models

Vo Thi Bich Thuy, Le Thi Nguyen Binh, Kim Thi Phuong Oanh, Nong Van Hai

Institute of Genome Research, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet, Cau Giay, Hanoi, Vietnam


Abstract: In several studies, scientists asserted that many of endocrine disruptors (EDs), which have been involved in developmental, reproductive, neural, immunological, and other problems in wildlife and laboratory animals. Some environmental EDs, such as di-(2-ethylhexyl) phthalate (DEHP), flutamide (Flu), parabens, are used in many products in life and environment. However, the adverse effects caused by EDs can be temporary or permanent and the mechanism(s) through which these chemicals elicit their effects on biological systems of human and animal health is not clearly understood. The specific aim of this study is to evaluate endocrine disrupting chemicals-induced impact on the male or female reproductive system. An attempt is also made to elucidate the impact of these EDs in an in vitro model, i.e., GH3 rat pituitary cell line. A great deal of work has been carried out on the toxicity of phthalate, Flu, parabens in vivo and in vitro models. In brief, studies have been indicated that long-term and short-term exposure to various endocrine disrupting compounds (i.e., DEHP, Flu, parabens) during development stage (i.e., gestation, neonatal, immature, peripubertal) were done to find alternative dysfunctions later in animal life. The development and function of male or female reproductive tract showed many abnormalities, e.g., menstrual cycle irregularities; impaired fertility, endometriosis, and polycystic ovarian syndrome in female or morphological and functional gonadal dysfunction, e.g., infertility and decreased libido, congenital malformations (altered embryonic and fetal intrauterine development) and testicular dysgenesis syndrome in male. In addition, the differential gene expression patterns by microarray analysis following EDs exposure were found, particularly in steroid hormone synthesis, androgen and/or estrogen synthesis, and sex determination-related gene. On the other hand, studies revealed that parabens, a weak estrogenic chemical, exerted their actions on the stimulation of CaBP-9k gene, an estrogenic biomarker, via binding to estrogen receptor and/or progesterone receptor in immature female rat and GH3 cell line. An increasing number of chemical compounds in the environment have been identified as endocrine disruptor in vivo and in vitro bioassay. A future challenge is required to confirm a theoretical toxicology and risk assessment of EDs for human and animal health.

Keywords: Endocrine disruptors (EDs); theoretical toxicology; risk assessment; reproductive system


Cite this abstract as: Thuy VT, Nguyen Binh LT, Phuong Oanh KT, Van Hai N. Endocrine disrupting chemicals: toxicological risk assessment in vivo and in vitro models. Ann Transl Med 2015;3(S2):AB159. doi: 10.3978/j.issn.2305-5839.2015.AB159

Download Citation